Relation between calculated LDL cholesterol and level of apolipoprotein B in subjects with normal and elevated levels of triglyerides;Vzt'ah kalkulovaného LDL cholesterolu k hladinám apolipoproteínu B u subjektov s normálnymi a zvýšenými hladinami triacylglycerolov

Kardiologia

Volumn 14, Issue 2, 2005, Pages 88-91

  Vachulová, Anna ^c   Vohnout, Branislav ^c   Blažíček, Pavol ^a   Fodor, George ^b   Lietava, Ján ^c  

^a Nemocnice Ministerstva Obrany ^*  (Slovakia)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c II Interná Klinika LFUK a FNsP Bratislava   (Slovakia)

Author keywords

Apolipoprotein B; Calculated LDL cholesterol; Hypertrilglyceridaemia

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AUTOANALYZER; CALCULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CORRELATION ANALYSIS; FEMALE; FRIEDEWALD FORMULA; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SLOVAKIA; TURBIDIMETRY;

EID: 17644393848     PISSN: 12100048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without the use of preparative ultra centrifugation. Clin Chem 1972;18:499-509.
2. Sniderman AD, Furberg CD, Keech A, et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777-780.
3. Bairaktari E, Elisaf M, Tzallas Ch, et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem 2001;34:593-602.
4. Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-2033.
5. Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-1 nad B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation 1996;94:273-278.
6. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517-2522.
7. Talmud PJ, Hawe E, Miller GJ, et al. Non-fasting apoB and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002;22:1918-1923.